_728349

HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-2CPR, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-3SAF, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-3SAG, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-3SAH, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-B1AKQ0, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-B1AKQ1, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-ENSG00000171824, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0000166, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0000176, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0000178, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0000184, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0000460, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0003723, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0004532, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0005730, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0005737, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0008408, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0009048, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0035327, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0071034, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0071035, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0071044, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0071048, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPI00009464, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPI00220336, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPR002121, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPR002562, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPR010997, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPR012337, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPR012588, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-NP_001001998.1, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-NP_002676.1, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-Q15158, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#UXR-EBI-358236, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#UXR-Q01780

Autoantigen PM/Scl 2, EXOSC10, P100 polymyositis-scleroderma overlap syndrome-associated autoantigen, PMSCL, PMSCL2, Polymyositis/scleroderma autoantigen 100 kDa, Polymyositis/scleroderma autoantigen 2, RRP6

Exosome component 10